noscript

News and Announcements

MedAdvisor Signs Agreement with Novartis Pharmaceuticals to Deliver Patient Engagement & Education Program

  • Published May 30, 2016 12:05PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

30th May 2016, ASX Announcement

Highlights:

  • MedAdvisor signs a 12 month agreement with Novartis Pharmaceuticals Australia to deliver patient engagement and education program via the MedAdvisor platform
  • Program will provide educational resources for patients, helping ensure they take their medications as prescribed to help improve patient adherence and quality use of medicines (QUMs)
  • The program is to commence in June 2016 with three products initially and will run for 12 months

MedAdvisor Limited (ASX:MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed a 12 month agreement to collaborate with Novartis Pharmaceuticals Australia.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now